Search results
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe
The Boston Globe· 7 days agoModerna said Friday that the European Patent Office has upheld the validity of one of its key...
Novavax Awaits FDA Decision on Whether Its Next COVID Shot Can Be Offered in US
US News & World Report· 52 minutes agoNovavax's updated vaccine targets a variant called JN.1, which is in line with European recommendations. The European Union's regulator told vaccine makers ...
Vaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines By Investing.com
Investing.com· 1 day agoVaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 1 day agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it was pulling ...
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 9 hours agoShares of vaccine stocks Moderna (MRNA 0.85%), Novavax (NVAX 3.17%), and BioNTech SE (BNTX -2.99%)...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 1 day agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 5 days agoPfizer and BioNTech were sued by Moderna in 2022. It accused them of using its patented mRNA...
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
Morningstar· 1 day agoOrganizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1 ...
Vaccine makers receive stock boost after third human bird flu case in US
Newsweek· 1 day agoShares in some companies that produce vaccines have seen stock boosts following a small number of...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoExperts are predicting a rise in COVID-19 cases, however, they expect the rise to be smaller than in...